Evans John M.: insider trades.
Evans John M. reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.7M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Evans John M.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Beam Therapeutics Inc. (BEAM) | Director, Officer · CEO | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Beam Therapeutics Inc. | M | 25,000 | $1.03 | 1,072,205 | Form 4 |
| 2026-06-30 | Beam Therapeutics Inc. | S | 23,100 | $34.26 | 1,049,105 | Form 4 |
| 2026-06-30 | Beam Therapeutics Inc. | S | 1,900 | $34.84 | 1,047,205 | Form 4 |
| 2026-06-29 | Beam Therapeutics Inc. | S | 11,579 | $35.91 | 1,047,205 | Form 4 |
| 2026-06-29 | Beam Therapeutics Inc. | S | 13,421 | $35.13 | 1,058,784 | Form 4 |
| 2026-06-29 | Beam Therapeutics Inc. | M | 6,337 | $1.03 | 1,072,205 | Form 4 |
| 2026-06-29 | Beam Therapeutics Inc. | M | 18,663 | $0.67 | 1,065,868 | Form 4 |
Questions
What stock did Evans John M. buy or sell?
Evans John M. reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.7M), across 1 company.
Is Evans John M. the same person as other filers with this name?
This page covers SEC CIK 1786304 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/evans-john-m-1786304.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.